Cleo vs iScribe Health
Detailed side-by-side comparison to help you choose the right tool
Cleo
Healthcare
AI-powered clinical decision support platform for acute care hospitals, providing real-time patient deterioration detection, sepsis prediction, and workflow optimization to improve outcomes and reduce clinician burnout.
Was this helpful?
Starting Price
CustomiScribe Health
Healthcare
AI-powered medical documentation tool that uses speech-to-text and generative AI to help healthcare professionals focus on patient care rather than paperwork.
Was this helpful?
Starting Price
CustomFeature Comparison
Scroll horizontally to compare details.
Cleo - Pros & Cons
Pros
- ✓Aims to consolidate deterioration detection, sepsis prediction, and capacity management into a single acute-care-focused platform, potentially reducing the need to procure and integrate multiple point solutions
- ✓Claims direct integration into existing EHR workflows (Epic, Cerner) so clinicians don't need to learn a separate application
- ✓Configurable alert sensitivity reportedly allows clinical informatics teams to tune the system to their facility's tolerance for alert fatigue
- ✓Describes explainable risk scores showing contributing factors, which if validated would enable clinicians to make informed decisions rather than relying on black-box outputs
- ✓Covers multiple acute care use cases within a single platform, unlike competitors that typically specialize in one domain (imaging, operations, or sepsis scoring alone)
Cons
- ✗Independent verification of the product, its customer base, and clinical outcomes is extremely limited — no peer-reviewed studies, named references, or specific outcome data are publicly available
- âś—Enterprise-only pricing (estimated at $50,000+/year based on comparable platforms) makes it inaccessible for small or rural hospitals without dedicated AI budgets
- âś—As a newer entrant, Cleo lacks the established install base and track record of competitors like Qventus, Viz.ai, or Epic's native tools, increasing procurement risk
- ✗Implementation requires a multi-week integration and calibration period, which may delay time-to-value by 2–3 months
- ✗Limited to acute care settings — organizations looking for outpatient, primary care, or population health AI will need a separate solution
- âś—FDA clearance status is not publicly documented, and no clinical validation studies are available in public databases such as PubMed
iScribe Health - Pros & Cons
Pros
- ✓Vendor states notes are returned to the EHR in 30 seconds or less, enabling providers to review documentation immediately after each encounter without workflow delays
- ✓Customizable AI output per provider allows each clinician to tailor note structure, terminology, and documentation style to their individual preferences rather than conforming to rigid templates
- ✓Vendor advertises same-day setup capability, which is faster than the weeks-long implementation timelines typical of enterprise health IT solutions, though actual timelines may vary by practice complexity
- ✓Practice-wide optimization beyond documentation—accelerates billing, scheduling, and prior authorizations that depend on completed notes, as demonstrated by vendor-reported $120,000 in annual savings at Florida Orthopaedic Institute
- ✓Ambient listening approach requires no structured dictation or voice commands, reducing workflow disruption during patient encounters
- ✓HIPAA-compliant infrastructure with encrypted data transmission and storage, meeting healthcare data security and privacy requirements
Cons
- âś—No publicly available pricing or transparent tier structure, making it difficult for individual providers or small practices to evaluate cost before engaging the sales team
- ✗As with all AI medical scribes, generated notes require clinician review and may contain errors in medical terminology, dosage details, or contextual interpretation—no independent accuracy benchmarks are publicly available
- âś—Primarily focused on outpatient and ambulatory care settings; suitability for inpatient, surgical, emergency department, or procedural workflows is unclear from available information
- âś—Fewer publicly available third-party reviews and independent validation studies compared to more established competitors like Nuance DAX Copilot, which has broader health system adoption
- âś—Enterprise sales cycle and custom quoting process may not be practical for solo practitioners or very small practices seeking quick, self-service deployment
Not sure which to pick?
🎯 Take our quiz →🦞
đź””
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.